NCT00793182View on ClinicalTrials.gov

Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography

PHASE4TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Renal Impairment
Interventions
DRUG

Ioversol 320 mgI/mL

125 mL of Ioversol administered in the vein

DRUG

Iodixanol 320 mgI/mL

125 mL of Iodixanol administered in the vein

Trial Locations (13)

17822

Geisinger Medical Center, Danville

19140

Temple University Hospital, Philadelphia

19141

Albert Einstein Medical Center, Philadelphia

20017

Providence Hospital, Washington D.C.

27612

Wake Research Associates, Raleigh

35233

UAB Hospital, Birmingham

44512

Radiology Consultants, Inc., Youngstown

48439

Genesys Regional Medical Center, Grand Blanc

61602

Methodist Medical Center of Illinois, Peoria

75701

Trinity Clinic, Tyler

85711

Radiology LTD, Tucson

114642

University of Rochester Medical Center, Rochester

04210

Maine Research Associates, Auburn

Sponsors

Lead Sponsor

Guerbet
All Listed Sponsors
lead

Guerbet

INDUSTRY

NCT00793182 - Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography | Biotech Hunter | Biotech Hunter